In an interview with the local newspaper Tubantia, we explain how we are building our 3D cardiac models and why our high-throughput technology is crucial to perform large drug screens for pharmaceutical companies.
In an interview with the local newspaper Tubantia, we explain how we are building our 3D cardiac models and why our high-throughput technology is crucial to perform large drug screens for pharmaceutical companies.